Bioxyne Limited BXN.AX Stock
Bioxyne Limited Price Chart
Bioxyne Limited BXN.AX Financial and Trading Overview
| Bioxyne Limited stock price | 0.0080 AUD |
| Previous Close | 0.02 AUD |
| Open | 0.02 AUD |
| Bid | 0.02 AUD x 0 |
| Ask | 0.02 AUD x 0 |
| Day's Range | 0.02 - 0.02 AUD |
| 52 Week Range | 0.01 - 0.03 AUD |
| Volume | 90K AUD |
| Avg. Volume | 78.45K AUD |
| Market Cap | 43.74M AUD |
| Beta (5Y Monthly) | 0.539846 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BXN.AX Valuation Measures
| Enterprise Value | 12.1M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 18.65072 |
| Price/Book (mrq) | 3.8333333 |
| Enterprise Value/Revenue | 5.158 |
| Enterprise Value/EBITDA | -56.561 |
Trading Information
Bioxyne Limited Stock Price History
| Beta (5Y Monthly) | 0.539846 |
| 52-Week Change | 76.92% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.03 AUD |
| 52 Week Low | 0.01 AUD |
| 50-Day Moving Average | 0.02 AUD |
| 200-Day Moving Average | 0.02 AUD |
BXN.AX Share Statistics
| Avg. Volume (3 month) | 78.45K AUD |
| Avg. Daily Volume (10-Days) | 207.19K AUD |
| Shares Outstanding | 1.9B |
| Float | 192.44M |
| Short Ratio | N/A |
| % Held by Insiders | 70.32% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -9.28% |
| Operating Margin (ttm) | -9.43% |
| Gross Margin | 43.60% |
| EBITDA Margin | -9.12% |
Management Effectiveness
| Return on Assets (ttm) | -3.50% |
| Return on Equity (ttm) | -10.34% |
Income Statement
| Revenue (ttm) | 2.35M AUD |
| Revenue Per Share (ttm) | 0.004 AUD |
| Quarterly Revenue Growth (yoy) | -9.90% |
| Gross Profit (ttm) | 1.22M AUD |
| EBITDA | -213879 AUD |
| Net Income Avi to Common (ttm) | -217848 AUD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | 409.00% |
Balance Sheet
| Total Cash (mrq) | 3.79M AUD |
| Total Cash Per Share (mrq) | 0.006 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.364 |
| Book Value Per Share (mrq) | 0.006 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -350468 AUD |
| Levered Free Cash Flow (ttm) | -296970 AUD |
Profile of Bioxyne Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | 50 Clarence Street |
| ZIP | 2000 |
| Phone | 61 2 9078 8180 |
| Website | https://www.bioxyne.com |
| Industry | Packaged Foods |
| Sector(s) | Consumer Defensive |
| Full Time Employees | N/A |
Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. It perates in two segments, Wholesale Sales and Direct Sales. The company engages in developing various functional foods and beauty products. Its products portfolio includes Progastrim for Gut and Immune Health; Progastrim plus Vitamin C for cold symptoms; and proTract for atopic dermatitis (eczema) for infants. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
Q&A For Bioxyne Limited Stock
What is a current BXN.AX stock price?
Bioxyne Limited BXN.AX stock price today per share is 0.0080 AUD.
How to purchase Bioxyne Limited stock?
You can buy BXN.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bioxyne Limited?
The stock symbol or ticker of Bioxyne Limited is BXN.AX.
Which industry does the Bioxyne Limited company belong to?
The Bioxyne Limited industry is Packaged Foods.
How many shares does Bioxyne Limited have in circulation?
The max supply of Bioxyne Limited shares is 1.9B.
What is Bioxyne Limited Price to Earnings Ratio (PE Ratio)?
Bioxyne Limited PE Ratio is now.
What was Bioxyne Limited earnings per share over the trailing 12 months (TTM)?
Bioxyne Limited EPS is -0.01 AUD over the trailing 12 months.
Which sector does the Bioxyne Limited company belong to?
The Bioxyne Limited sector is Consumer Defensive.